Regenhu SA
Villaz, FR
- UEI
- KNM2S6AH4YZ4
- CAGE
- SAQS8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- Le Vivier 22, 1690 Villaz-Saint-Pierre, Switzerland
- Website
- regenhu.com
- Founded
- 2007
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $10,285 |
| FY2023 | $47,709 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Regenhu SA, registered in SAM.gov since February 2016 and based in Villaz-Saint-Pierre, Switzerland, is a for-profit international organization specializing in advanced bioprinting technology and equipment. The company develops sophisticated 3D bioprinting platforms and systems designed to support medical and scientific research, with a primary focus on creating innovative solutions for tissue modeling and biological research applications. As a global manufacturer of bioprinting equipment, Regenhu SA has established itself as a key provider of cutting-edge technological solutions for research institutions and government agencies seeking advanced bioengineering capabilities.
Through its federal contract awards, Regenhu SA has consistently provided high-value bioprinting stations and related equipment to multiple U.S. government agencies, including the Department of Health and Human Services' National Institutes of Health, the National Center for Advancing Translational Sciences, and the Department of Veterans Affairs. The company's contract awards, ranging from $10,285.27 to $336,301.88, have focused on delivering comprehensive 3D bioprinting platforms capable of multiple printing techniques such as inkjet-based, extrusion-based, laser-assisted, and stereolithographic bioprinting. These awards have supported critical research programs involving complex scientific investigations into disease models, neuronal circuits, neuromuscular junctions, pain, and addiction. Notably, none of Regenhu SA's federal contract awards have utilized specific set-aside programs, and the contracts have been awarded as standard purchase orders across various federal agencies' research and medical divisions.
Quick answers
Is Regenhu SA registered in SAM.gov?
Yes. Regenhu SA's SAM.gov registration is active through March 24, 2027.
How much has Regenhu SA received in federal contracts?
Federal contracts obligated $57,994 to Regenhu SA in fiscal years 2023 through 2027.
What is Regenhu SA's most recent federal award?
Regenhu SA's most recent federal contract award is Volumetric cartridge - 2.5ML# and 5ML (75N95C24P00058), from National Center for Advancing Translational Sciences (NIH), on May 24, 2024.
On GovTribe
See Regenhu SA's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors